Recombinant Human NKG2DL (C-Fc)(Cat. No.:CK50) novoprotein

$95.00
In stock
SKU
CK50
10μg: $95 50μg: $250 500μg: $1540 1mg: $2200

Description

Recombinant Human UL16 Binding Protein-1/NKG2D Ligand 1 is produced by our Mammalian expression system and the target gene encoding Gly26-Pro215 is expressed with a human IgG1 Fc tag at the C-terminus.

Product Details

ItemDetails
Known AsNKG2D ligand 1; NKG2DL1; ALCAN-beta; Retinoic acid early transcript 1I; UL16-binding protein 1; ULBP1
Mol Mass49.4 KDa
APMol Mass58-70 KDa, reducing conditions
Formulation DescriptionLyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
Endotoxin< 1 EU/µg as determined by LAL test.
ReconstitutionAlways centrifuge tubes before opening.Do not mix by vortex or pipetting.
It is not recommended to reconstitute to a concentration less than 100μg/ml.
Dissolve the lyophilized protein in distilled water.
Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
StorageLyophilized protein should be stored at ≤ -20°C, stable for one year after receipt.
Reconstituted protein solution can be stored at 2-8°C for 2-7 days.
Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months.
ShippingThe product is shipped at ambient temperature.
Upon receipt, store it immediately at the temperature listed below.

Background

NKG2D ligand 1, also called ULBP1, is a member of UL16-binding protein (ULBP) family which has also been termed the retinoic acid early transcript 1 (RAET1) family. Unlike the classical MHC class I molecules and the MIC molecules possess α1, α2 and α3 domains, ULBP/RAET1 family members lack α3 domain. ULBP1 is recognized by the activating receptor NKG2D on the surface of cytotoxic natural killer (NK) and T cells, and then promotes the lysis of cells expressing ULBP1 which is important for the immune surveillance. ULBP1 and several other family members, ULBP2 and ULBP5, own the ability to bind the human cytomegalovirus (CMV) UL16 glycoprotein. The human CMV glycoprotein UL16 binds to intracellular ULBP1 and so inhibits its expression at the cell surface, which reduces the susceptibility of the virus-infected cell to cytotoxic destruction by NK cells. The expression of ULBP1 has been found on some tumor cells and is implicated in tumor surveillance.

title: Dihydroartemisinin enhances NKG2D CAR-T cell therapy against solid tumors by inducing NKG2D ligands and remodeling the tumor microenvironment
authors: Muhammad Auwal Saliu, Mansur Dabai Salisu, Rabiatu Bako Suleiman, Wei Liang, Lawan Rabiu, Nada Mohamady Farouk Abdalsalam, Lukman Olalekan Afolabi, Isaac Adeyemi Babarinde, Adeleye O Adeshakin, Zhiming Xu, Xiaochun Wan, Maoxuan Liu
date: 2026/01/12
journal: BIOMEDICINE & PHARMACOTHERAPY

MDSD

Datasheet

Reviews

Write Your Own Review
You're reviewing:Recombinant Human NKG2DL (C-Fc)(Cat. No.:CK50) novoprotein
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.